Association of Nasopharynx Cancer with Human Papillomavirus Infections
- PMID: 37627110
- PMCID: PMC10452438
- DOI: 10.3390/cancers15164082
Association of Nasopharynx Cancer with Human Papillomavirus Infections
Abstract
This population-based study aims to examine the association between nasopharyngeal carcinoma and human papillomavirus infections. This study included 2747 individuals aged 20 years and older who were diagnosed with nasopharynx cancer as cases and 13,735 propensity-score-matching controls. Multivariate logistic regression models were employed to quantitatively assess the association of nasopharynx cancer with human papillomavirus infections while considering age, sex, monthly income, geographic location, and urbanization level of the patient's residence as well as diabetes, hypertension, and hyperlipidemia. Our chi-squared test indicated a significant dissimilarity in previous human papillomavirus infection rates between nasopharynx cancer patients and controls (12.7% vs. 7.2%, p < 0.001). The adjusted odds ratio (OR) for prior human papillomavirus infections was found to be significantly higher for nasopharyngeal carcinoma cases compared to controls at a value of 1.869 with confidence interval ranging from 1.640 to 2.128. Among female participants, compared to controls, the adjusted OR of prior human papillomavirus infections was 2.150 (95% CI = 1.763-2.626) in patients with nasopharynx cancer. In male participants sampled in this study, we observed a statistically significant association between prior human papillomavirus infections and nasopharynx cancer (adjusted OR = 1.689; 95% CI = 1.421-2.008). Our study indicates a noteworthy association between previous human papillomavirus infections and nasopharyngeal carcinoma.
Keywords: epidemiology; human papillomavirus; human papillomavirus infection; nasopharyngeal carcinoma.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Association of prostate cancer with human papillomavirus infections: a case-control study.Prostate Cancer Prostatic Dis. 2024 Dec;27(4):743-748. doi: 10.1038/s41391-023-00772-1. Epub 2023 Dec 14. Prostate Cancer Prostatic Dis. 2024. PMID: 38092969
-
Association of thyroid cancer with human papillomavirus infections.Sci Rep. 2024 Jan 3;14(1):431. doi: 10.1038/s41598-023-49123-z. Sci Rep. 2024. PMID: 38172564 Free PMC article.
-
Association of salivary gland cancer with human papillomavirus infections.Eur Arch Otorhinolaryngol. 2025 Jan;282(1):403-408. doi: 10.1007/s00405-024-08906-4. Epub 2024 Aug 23. Eur Arch Otorhinolaryngol. 2025. PMID: 39179913
-
Association of Peripheral Vestibular Disorder with Diabetes: A Population-Based Study.J Pers Med. 2024 Jul 19;14(7):768. doi: 10.3390/jpm14070768. J Pers Med. 2024. PMID: 39064022 Free PMC article.
-
Human papillomavirus-associated neoplasms of the sinonasal tract and nasopharynx.Semin Diagn Pathol. 2016 Mar;33(2):104-11. doi: 10.1053/j.semdp.2015.09.011. Epub 2015 Sep 9. Semin Diagn Pathol. 2016. PMID: 26482046 Review.
Cited by
-
RNF138 contributes to cisplatin resistance in nasopharyngeal carcinoma cells.Sci Rep. 2025 Jan 9;15(1):1406. doi: 10.1038/s41598-025-85716-6. Sci Rep. 2025. PMID: 39789198 Free PMC article.
-
Developing a robust two-step machine learning multiclassification pipeline to predict primary site in head and neck carcinoma from lymph nodes.Heliyon. 2024 Jan 12;10(2):e24377. doi: 10.1016/j.heliyon.2024.e24377. eCollection 2024 Jan 30. Heliyon. 2024. PMID: 38312621 Free PMC article.
-
Association of prostate cancer with human papillomavirus infections: a case-control study.Prostate Cancer Prostatic Dis. 2024 Dec;27(4):743-748. doi: 10.1038/s41391-023-00772-1. Epub 2023 Dec 14. Prostate Cancer Prostatic Dis. 2024. PMID: 38092969
-
Epidemiology of nasopharyngeal carcinoma: current insights and future outlook.Cancer Metastasis Rev. 2024 Sep;43(3):919-939. doi: 10.1007/s10555-024-10176-9. Epub 2024 Mar 2. Cancer Metastasis Rev. 2024. PMID: 38430391 Review.
-
Individual and community-level social determinant impact on HPV-differentiated nasopharyngeal carcinoma disparities in the USA.Sci Rep. 2025 Jul 23;15(1):26778. doi: 10.1038/s41598-025-10522-z. Sci Rep. 2025. PMID: 40702052 Free PMC article.
References
-
- Nakanishi Y., Wakisaka N., Kondo S., Endo K., Sugimoto H., Hatano M., Ueno T., Ishikawa K., Yoshizaki T. Progression of understanding for the role of Epstein-Barr virus and management of nasopharyngeal carcinoma. Cancer Metastasis Rev. 2017;36:435–447. doi: 10.1007/s10555-017-9693-x. - DOI - PMC - PubMed
-
- Zhang Y., Fan J., Fan Y., Li L., He X., Xiang Q., Mu J., Zhou D., Sun X., Yang Y., et al. The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest. Clin. Epigenetics. 2018;10:26. doi: 10.1186/s13148-018-0459-2. - DOI - PMC - PubMed
-
- Raab-Traub N. Seminars in Cancer Biology. Elsevier; Amsterdam, The Netherlands: 2002. Epstein–Barr Virus in the Pathogenesis of NPC. - PubMed
-
- Dawson C.W., Port R.J., Young L.S. Seminars in Cancer Biology. Elsevier; Amsterdam, The Netherlands: 2012. The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC) - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources